A study of more than ten-thousand women has found a genetic test can identify those who can safely skip chemotherapy.
The study looked at women with the most common forms of early-stage breast cancer.
Doctors say using the test to analyse early-stage tumours will help identify those that can be treated with surgery and hormone therapy alone.